Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $326.99 | 7 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Allergan Inc. | $189.48 | 2 | $0 (2018) |
| ABBVIE INC. | $65.98 | 3 | $0 (2024) |
| MERZ NORTH AMERICA, INC. | $45.92 | 1 | $0 (2017) |
| Amgen Inc. | $25.61 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $44.68 | 2 | ABBVIE INC. ($44.68) |
| 2023 | $21.30 | 1 | ABBVIE INC. ($21.30) |
| 2019 | $25.61 | 1 | Amgen Inc. ($25.61) |
| 2018 | $189.48 | 2 | Allergan Inc. ($189.48) |
| 2017 | $45.92 | 1 | MERZ NORTH AMERICA, INC. ($45.92) |
All Payment Transactions
7 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/03/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $18.72 | General |
| 10/28/2024 | ABBVIE INC. | BOTOX (Biological), QULIPTA | Food and Beverage | In-kind items and services | $25.96 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 10/13/2023 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $21.30 | General |
| Category: NEUROSCIENCE | ||||||
| 12/06/2019 | Amgen Inc. | Aimovig (Biological) | Food and Beverage | In-kind items and services | $25.61 | General |
| Category: Neuroscience | ||||||
| 06/01/2018 | Allergan Inc. | BOTOX - NEUROLOGY (Drug) | Food and Beverage | In-kind items and services | $140.07 | General |
| Category: NEUROSCIENCE | ||||||
| 05/04/2018 | Allergan Inc. | BOTOX - NEUROLOGY (Drug) | Food and Beverage | In-kind items and services | $49.41 | General |
| Category: NEUROSCIENCE | ||||||
| 12/02/2017 | MERZ NORTH AMERICA, INC. | Xeomin (Biological) | Food and Beverage | Cash or cash equivalent | $45.92 | General |
| Category: Musculoskeletal | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 108 | 6,234 | $183,900 | $49,009 |
| 2022 | 3 | 61 | 141 | $67,090 | $11,600 |
| 2021 | 3 | 97 | 210 | $75,790 | $15,536 |
| 2020 | 6 | 159 | 401 | $89,122 | $15,410 |
All Medicare Procedures & Services
22 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2023 | 20 | 6,002 | $90,030 | $29,763 | 33.1% |
| 64615 | Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face | Office | 2023 | 23 | 77 | $43,120 | $8,173 | 19.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 41 | 65 | $26,000 | $5,781 | 22.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 13 | 61 | $16,775 | $3,836 | 22.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 11 | 29 | $7,975 | $1,457 | 18.3% |
| 64615 | Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face | Office | 2022 | 20 | 67 | $36,620 | $6,616 | 18.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 30 | 45 | $18,000 | $3,285 | 18.3% |
| 64405 | Injection of anesthetic agent and/or steroid into upper neck and back of head nerve | Office | 2022 | 11 | 29 | $12,470 | $1,698 | 13.6% |
| 64615 | Injection of chemical for destruction of facial and neck nerve muscles on both sides of face | Office | 2021 | 22 | 49 | $23,765 | $5,088 | 21.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 20 | 82 | $22,550 | $4,570 | 20.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 28 | 43 | $17,200 | $3,154 | 18.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 16 | 19 | $7,600 | $1,762 | 23.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 11 | 17 | $4,675 | $962.45 | 20.6% |
| 64615 | Injection of chemical for destruction of facial and neck nerve muscles on both sides of face | Office | 2020 | 20 | 40 | $19,400 | $4,084 | 21.0% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Facility | 2020 | 16 | 62 | $17,050 | $2,652 | 15.6% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 33 | 42 | $16,800 | $2,650 | 15.8% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour | Office | 2020 | 15 | 36 | $7,560 | $1,996 | 26.4% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 17 | 21 | $8,400 | $1,442 | 17.2% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 15 | 25 | $6,875 | $1,110 | 16.1% |
| 64615 | Injection of chemical for destruction of facial and neck nerve muscles on both sides of face | Facility | 2020 | 16 | 16 | $7,760 | $816.76 | 10.5% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Facility | 2020 | 12 | 15 | $4,125 | $604.02 | 14.6% |
| J3475 | Injection, magnesium sulfate, per 500 mg | Office | 2020 | 15 | 144 | $1,152 | $54.60 | 4.7% |
About Dr. Lauren Green, D.O
Dr. Lauren Green, D.O is a Neurology healthcare provider based in Los Angeles, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/20/2008. The National Provider Identifier (NPI) number assigned to this provider is 1972764009.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Lauren Green, D.O has received a total of $326.99 in payments from pharmaceutical and medical device companies, with $44.68 received in 2024. These payments were reported across 7 transactions from 4 companies. The most common payment nature is "Food and Beverage" ($326.99).
As a Medicare-enrolled provider, Green has provided services to 425 Medicare beneficiaries, totaling 6,986 services with total Medicare billing of $91,555. Data is available for 4 years (2020–2023), covering 22 distinct procedure/service records.
Practice Information
- Specialty Neurology
- Location Los Angeles, CA
- Active Since 06/20/2008
- Last Updated 12/02/2020
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1972764009
Products in Payments
- BOTOX - NEUROLOGY (Drug) $189.48
- Xeomin (Biological) $45.92
- BOTOX (Biological) $25.96
- Aimovig (Biological) $25.61
- QULIPTA (Drug) $21.30
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Los Angeles
Dr. Andrew Blumenfeld, M.d, M.D
Neurology — Payments: $6.2M
Jeffrey Cummings, Md, MD
Neurology — Payments: $1.2M
Dr. Alan Rapoport, M.d, M.D
Neurology — Payments: $1.0M
Said Beydoun, M.d, M.D
Neurology — Payments: $967,384
Mark Lew, M.d, M.D
Neurology — Payments: $735,848
Dr. Dawn Eliashiv, M.d, M.D
Neurology — Payments: $465,988